BU-NOT-SET

CONTACT US
Nitrosamines analysis
  • Analytical chemistry
Nitrosamines analysis
Fact sheet
Enabling oral solid dosage form delivery of biologics
  • Biologics
  • Drug substance
oral biologics
Insight
Plasmid DNA manufacturing capabilities
  • Biologics
plasmid DNA manufacturing
Fact sheet
Leveraging analytics throughout development and manufacture to achieve commercial success
  • Analytical chemistry
  • Drug substance
development
Insight
2,300 solar panels installed at Recipharm’s Holmes Chapel
  • Sustainability
solar panels
Insight
Analysing prebiotic oligosaccharides for future product innovation
  • Analytical chemistry
  • Drug substance
Workers
White paper
Enhancing sterile processing for future vaccine programs
  • Industry trends
  • Manufacturing
Manufacturing
Insight
Increasing carbon emission transparency through SBTi contributions
  • Sustainability
SBTi
Insight
Single-use technologies are enabling increasing demand for biologics
  • Biologics
People
Insight
Insight
  • Analytical chemistry
  • Industry trends
An expert’s guide to analytical services
Insight
  • Drug product
  • Manufacturing
How Lyophilisation can help overcome mRNA stability challenges
Insight
  • Drug product
  • Manufacturing
How pre-filled syringes are changing drug delivery of biologics
Webinar
  • Drug product
Choosing the right sterile container for your drug product
Video
  • Manufacturing
ReciBioPharm is Advancing the Future of xRNA Manufacturing
Webinar
  • Biologics
  • Manufacturing
Faster, Smaller, Smarter: Intelligent Manufacturing of mRNA Through The Power of Process Analytical Technologies
Insight
  • Biologics
ReciBioPharm: The Economic Case for Continuous Manufacturing
Insight
  • Drug product
  • Manufacturing
The innovation bottleneck: Why drug development is so tough, and how connectivity and predictive analysis can overcome obstacles
Insight
  • Industry trends
What are the key trends shaping drug development in 2025?